Acute Myeloid Leukemia (AML)


German Government Injects €2.45m to ‘Get to Root of Problem’ of Leukemia: Preliminary Stem Cell-based Research

The German Federal Ministry of Education and Research (BMBF), has transferred €2.45m to a research collaborative known as LeukoSyStem to “get to the root of the problem” of leukemia. With an emphasis on stem cell research and “the starting point of leukemia,” the...

Acute Myeloid Leukemia Phase III Clinical Trials Activates 25 Sites and Gains Momentum with Prominent Leukemia-Focused Investigator at Helm

Rafael Pharmaceuticals reported that 25 sites have been activated in the pivotal Phase III ARMADA 2000 clinical trial of CPI613® (devimistat) in older patients with relapsed or refractory acute myeloid leukemia (AML). Dr. Jorge Cortes, Director of Georgia Cancer...

Pin It on Pinterest